Special Stockholders Meeting to Elect Directors Set for March 4, 2008

OLDSMAR, Fla., Jan. 22 /PRNewswire-FirstCall/ -- The Delaware Court of
Chancery today issued its Order and Final Judgment in a case brought by a
stockholder of Cryo-Cell International Inc. (OTC Bulletin Board: CCEL)
challenging the election results of the annual meeting of stockholders held on
July 16, 2007. The court ordered the Company to hold a new election of
directors at a special stockholders meeting to be held on March 4, 2008,
commencing at 3:00 p.m., EST. The record date for the purpose of determining
stockholders entitled to notice of and to vote at the special meeting is
January 18, 2008. The directors who sat on the Cryo-Cell Board of Directors
prior to the 2007 annual meeting will continue in office until the special
meeting of stockholders is held.
The Company will provide additional information about the meeting when it
is available.
About Cryo-Cell International Inc.
Based in Oldsmar, Florida, with over 140,000 clients worldwide, Cryo-Cell
is one of the largest and most established family cord blood banks. ISO
9001:2000 certified and accredited by the AABB, Cryo-Cell operates in a
state-of-the-art Good Manufacturing Practice and Good Tissue Practice
(cGMP/cGTP)-compliant facility. Cryo-Cell is a publicly traded company. OTC
Bulletin Board Symbol: CCEL. For more information, please call 1-800-STOR-CELL
(1-800-786-7235) or visit http://www.cryo-cell.com.
Cryo-Cell expects to file a proxy statement with the Securities and
Exchange Commission and to send the proxy statement to shareholders in
connection with this special meeting to elect directors. The Company urges
investors and stockholders to read the proxy statement carefully when it is
available. The proxy statement will contain important information about the
proposals to be brought before the annual meeting. Investors and shareholders
will be able to obtain free copies of the proxy statement, once available, as
well as other filings made by the Company with the Commission, through the Web
site maintained by the Commission at http://www.sec.gov. Free copies of the
proxy statement, once available, may also be obtained by stockholders by
directing a request to the Company at: Cryo-Cell International, Inc., 700
Brooker Creek Blvd., Suite 1800, Oldsmar, Florida 34677, Attention: Corporate
Secretary.
Cryo-Cell, its directors, executive officers and certain other members of
management and employees may be soliciting proxies from the Company's
stockholders in connection with the special meeting. Information concerning
the Company is set forth in its filings with the Commission and information
regarding other possible participants in the solicitation is set forth in the
Company's proxy statement filed by the Company with the Commission on June 8,
2007.
Contact:
Jill Taymans, Chief Financial Officer
Phone: 813-749-2104
E-mail: jtaymans@cryo-cell.com

SOURCE Cryo-Cell International Inc.

Jill Taymans, Chief Financial Officer of Cryo-Cell International Inc.,
+1-813-749-2104, jtaymans@cryo-cell.com